Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.
Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.
EsoBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Ossium Health builds a bone marrow bank to treat blood cancers.
Ocelot Bio brings new treatment options to patients with severe liver disease.
IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.
OCI develops therapies for leukaemia based on CAR–T.
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.
Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.
Pulmobiotics is a pre-clinical life sciences company.
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.
Bonum Therapeutics creates a technology platform to treat a wide range of diseases.
Tricida operates in the healthcare industry focusing on pharmaceutical business.
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
Atekka is a new generation agricultural insurance company.
Inspirna is a biotechnology company developing drugs for the treatment of cancer.
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Visirna Therapeutics to develop and commercialize RNAi therapeutics targeting cardiovascular and metabolic diseases.
Aerobiotix is a privately held company specializing in the development and manufacture of proprietary environmental management devices.
Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.
Vivo Capital has invested in 165 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Vivo Capital's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 18 different industry categories.
Among tracked funding rounds, Legend Biotech received $350.0M in a Post Ipo Equity round. Vivo Capital's total known invested capital is $17.2B.
Vivo Capital's average investment size is $136.5M across its portfolio of 165 companies.
Recent Vivo Capital portfolio additions include Tourmaline Bio, Avistone Pharmaceuticals, EsoBiotec, Poseida Therapeutics, Gracell Biotechnologies. These companies were founded in 2020 or later.